Association of ACEI/ARB, inflammatory cytokines, and antiviral drugs with liver dysfunction in patients with hypertension and COVID-19

Association of ACEI/ARB, inflammatory cytokines, and antiviral drugs with liver dysfunction in patients with hypertension and COVID-19

Background: Currently, SARS-CoV-2 liver invasion, inflammatory cytokines, and antiviral drugs are widely thought to be associated with liver dysfunction in COVID-19 patients. Besides, previous studies indicated that ACEI/ARB drugs can increase the expression of hepatic ACE2, a cell entry receptor fo...

Descripció completa

Dades bibliogràfiques
Autors principals: Dong Xiang, Xiuhua Ren, Qian Chen, Hengyi Yu, Xiping Li, Dong Liu
Format: Article
Idioma:English
Publicat: Taylor & Francis Group 2021-05-01
Col·lecció:Clinical and Experimental Hypertension
Matèries:
covid-19
liver dysfunction
hypertension
sars-cov-2
ace2
inflammatory cytokine
antiviral drug
Accés en línia:http://dx.doi.org/10.1080/10641963.2020.1867160

Internet

http://dx.doi.org/10.1080/10641963.2020.1867160

Ítems similars